Qualified Treatment Centers for Pfizer gene therapies
Pfizer is committed to ensuring eligible patients have access to hemophilia gene therapy. We are working with institutions to develop a network of Qualified Treatment Centers (QTCs) across the United States that are ready to administer Pfizer gene therapies. The administration of Pfizer gene therapies requires specialized infrastructure and training to handle, administer, and monitor gene therapy products. Use the search filters to find the treatment center closest to you.
Have questions?
A Pfizer Patient Affairs Liaison, or PAL, is a resource available to patients and caregivers who can help answer Pfizer product questions and provide access to educational resources, programs, and other helpful information about hemophilia.
Activated Treatment Center
Able to check patient eligibility through testing and administer gene therapy
Activation-in-Progress Treatment Center
Undergoing required training to test patients and administer gene therapy
Additional sites might be available, but not yet listed. Please contact Pfizer GeneTogether or a PAL with questions or to find the most updated list of centers available.
Treatment centers interested in becoming a part of Pfizer's QTC network for gene therapies can reach out by email for more information.
- QTCs* are independently owned and operated
- Pfizer does not supervise any medical care conducted by the QTCs
- Pfizer does not endorse any individual QTC or provider
- Treatment centers that are activated and those with activation in progress have completed or are working to complete Pfizer's qualification process
*QTC=qualified treatment center.